- Conditions
- Advanced Breast Cancer, Breast Cancer Metastatic, HER2 Low Breast Carcinoma, +1 more
- Locations
-
- Gustave Roussy Institut Villejuif, France
Clinical trial condition
HER2 Low Breast Carcinoma
Explore clinical trials studying HER2 Low Breast Carcinoma. Study availability and eligibility vary by location and protocol.
7 public trials
5 recruiting studies
HER2 Low Breast Carcinoma trial results
NCT05868226
- Conditions
- Adenocarcinoma, Adenocarcinoma of Colon, Breast Diseases, +51 more
- Locations
-
- The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
- Moffitt Cancer Center Tampa, Florida, United States
- The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
- UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
Recruiting
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
NCT06224673
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Low Breast Carcinoma, +8 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT07198724
- Conditions
- Breast Cancer, Breast Cancer Female, Breast Diseases, +8 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT05911958
- Conditions
- HER2 Low Breast Carcinoma
- Locations
-
- Henan Cancer Hospital Zhengzhou, Henan, China
Active, not recruiting
Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer
NCT06144944
- Conditions
- Breast Cancer Invasive, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China
NCT05754047
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Low Breast Carcinoma, +4 more
- Locations
-
Not specified